Today: 10 June 2026
Melrose Industries share price sinks 13% as 2026 outlook spooks investors
27 February 2026
1 min read

Melrose Industries share price sinks 13% as 2026 outlook spooks investors

London, February 27, 2026, 11:21 GMT — Regular session

  • Melrose shares dropped after the company signaled it expects lower revenue in 2026.
  • Despite a solid 2025 performance, supply-chain snags and doubts around tariffs took the spotlight.
  • The group has increased its dividend and rolled out a new share buyback programme.

Shares of Melrose Industries PLC slid 13.4% to 554 pence as of 11:06 GMT Friday, putting the GKN Aerospace parent at the bottom of the FTSE 100. The stock touched a session low of 536.8 pence after investors balked at the company’s guidance for 2026.

This slide is grabbing attention because aerospace suppliers are being judged on their ability to convert historic demand into actual shipments—not on last year’s recovery. Melrose cited ongoing supply-chain snags and uncertainty linked to U.S. trade policy, and put its 2026 revenue outlook at 3.75 billion to 3.95 billion pounds, trailing the 4.01 billion analysts penciled in. Chief Executive Peter Dilnot told Reuters that chokepoints at Airbus, Pratt & Whitney and GE remain the biggest headache for meeting orders.

Melrose said 2025 revenue was up 8% to 3.589 billion pounds, with adjusted operating profit jumping 23% to 647 million pounds. Free cash flow came in at 125 million pounds. The company also set out plans for a fresh 175 million pound share buyback, targeting completion by end-March 2027. The final dividend moves 20% higher to 4.8 pence per share, due May 5 for holders recorded as of March 20 close.

Melrose is positioning as a focused aerospace and defence supplier, manufacturing engine and airframe parts via GKN Aerospace. Increasingly, profits are being driven by the “aftermarket” — essentially, repairs and spare parts for planes already in service. That business is typically more stable than revenue from new aircraft production.

The action Friday underscored just how fast “guidance” can overshadow headline earnings. Hopes around smoother production ramps are still in play, but behind the scenes, the process remains tangled. Even minor hiccups at major planemakers can cascade.

This week, other UK aerospace stocks have told a different story. Rolls-Royce jumped the previous day, buoyed by a raised outlook and a new 2026–2028 buyback plan, setting the tone ahead of Melrose’s results.

Melrose put it less bluntly—demand’s not the issue, it’s whether capacity can keep up. Investors, meanwhile, are left weighing tariff risks and unpredictable trade tensions that reshuffle costs before contracts even catch up.

Risks here aren’t subtle—and they’re hardly minor. Ongoing shortages or shaky build rates at key customers could push deliveries into future quarters, squeezing margins as suppliers shell out more for labor, parts, and rush shipping.

Stock Market Today

  • Live Cattle Futures Rally As USDA Reports Steady Slaughter and Strong Auction Prices
    June 10, 2026, 5:26 AM EDT. Live cattle futures rebounded Tuesday with gains of $1.50 to $2.97 across contracts, led by August 2025 delivery. Feeder cattle futures jumped $2.00 to $3.45, supported by a $5.63 increase in the CME Feeder Cattle Index to 367.01. The weekly Oklahoma City feeder cattle auction saw steady to higher prices, with feeder steers up as much as $10 and heifers rising $2-$8. USDA-reported fed cattle slaughter totaled 109,000 head Tuesday, down week-over-week and year-over-year. Boxed beef prices mixed, with Choice boxes rising 70 cents and Select falling $1.16. The USDA pasture rating improved slightly. Market activity suggests resilience amid tight supplies and solid demand, bolstering cattle futures.

Latest articles

Ondas Stock Comes Back Into the Spotlight After 13% Drop; Drone Trade Faces Fresh Challenge

Ondas Dips Premarket After 2.7 Million-Share Filing

10 June 2026
SoFi Technologies traded near $16.47 in early premarket, little changed as investors weighed its AI and digital asset product push against a risk-off market mood, with no fresh earnings news and inflation data looming that could impact rates, loan demand, and fintech valuations.

SoFi Stock Faces a Crucial Pre-Market Test as Wall Street Turns Defensive

10 June 2026
Rolls-Royce shares rebounded 1.5% in London after Tuesday’s 2.68% drop, as investors weighed fresh airline criticism over engine delays against the company’s reaffirmed 2026 profit and cash flow guidance; CEO Tufan Erginbilgic said Rolls had a “strong start to the year,” but risks remain if airline pressure leads to higher costs or slower cash conversion.
LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

10 June 2026
LVMH shares slipped 0.49% to €489.90 in Paris after a four-day rebound, as investors weighed RBC’s reiterated Buy rating with a €600 target against ongoing 2026 losses and a 24% year-to-date drop; all eyes now turn to July’s first-half results for signs of recovery in Fashion & Leather Goods and any relief from Middle East weakness.
Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

10 June 2026
Roche’s participation certificates climbed 1.07% to CHF 322.20 after announcing a $2.3 billion deal with Nurix Therapeutics for late-stage blood-cancer drug bexobrutideg, planned to enter Phase 3 trials this summer in CLL, as investors weigh the asset’s potential to offset losses from expiring patents and drive mid-single-digit sales growth in 2026.
YY Group Shares Jump Premarket on Humanoid Robot Move

YY Group Shares Jump Premarket on Humanoid Robot Move

10 June 2026
YYGH jumped to $0.19 in early pre-market after announcing deployment of Unitree G1 humanoid robots for facility management, aiming to turn operational know-how into higher-margin data assets, but the stock remains volatile near record lows after a recent reverse split and has not confirmed robot-driven revenue or margin gains.
GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal
Previous Story

GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal

CBA’s $1 Billion Mortgage Fraud Alarm: Big Banks Face New AI-Document Threat
Next Story

CBA’s $1 Billion Mortgage Fraud Alarm: Big Banks Face New AI-Document Threat

Go toTop